Evidence map›Paper›PMID 32884746›Full record

ArticleJournal of animal science and biotechnology2020

Development of an

S E Sivinski, L K Mamedova, R A Rusk, C C Elrod, T H Swartz, J M McGill, B J Bradford

Open access · goldAbstract read
In one paragraph

Article in Journal of animal science and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Developing anACS pharmacology & translational science · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A comprehensive insight into the anti-inflammatory properties of dapsone.Naunyn-Schmiedeberg's archives of pharmacology · 2022
    Review
  13. Beta-Glucan fromInternational journal of molecular sciences · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

S E SivinskiDepartment of Animal Sciences and Industry, Kansas State University, Manhattan, 66506 USA.
L K MamedovaDepartment of Animal Sciences and Industry, Kansas State University, Manhattan, 66506 USA.
R A RuskDepartment of Diagnostic Medicine/Pathobiology, Kansas State University, Manhattan, 66506 USA.
C C ElrodNatural Biologics, Newfield, NY 14867 USA.
T H SwartzDepartment of Animal Sciences and Industry, Kansas State University, Manhattan, 66506 USA.
J M McGillDepartment of Diagnostic Medicine/Pathobiology, Kansas State University, Manhattan, 66506 USA.
B J BradfordDepartment of Animal Sciences and Industry, Kansas State University, Manhattan, 66506 USA.ORCID 0000-0002-6775-4961
Kansas State University · USUS Biologic (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhile feed components capable of modulating the immune system are highly sought after and marketed, often little evidence is available to support functional immune response claims. Thus, a high-throughput

resultsTreatment with zymosan or β-glucan alone induced NFκB activation in a dose-dependent manner, whereas treatment with

conclusionsOverall, this cell screening system using RAW macrophages was effective, high-throughput, and sensitive to feed components combined with LPS challenges, indicating modulation of innate immune signaling GRAPHICAL ABSTRACT:

Indexed as

InflammationIn vitro screening systemNFκB

Identifiers

PMID32884746
PMCPMC7460759
OpenAlexW3082970809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.